Skip to main content

Table 1 Standards, criteria and targets used in gout audit

From: Improvement in the management of gout is vital and overdue: an audit from a UK primary care medical practice

Theme of care Guideline statement Criteria Standards
Assessment of gout patients All patients presenting with acute gout should have SUA, renal function and glucose assessed 4-6wk after acute attack [3] 1.1 Adult patients with a diagnosis of gout have ever had a recorded SUA ≥90%
1.2 Adult patients with a diagnosis of gout have ever had a recorded eGFR ≥90%
1.3 Adult patients with a diagnosis of gout have had a recorded serum glucose since diagnosis ≥90%
Management of recurrent gout The therapeutic goal of urate lowering therapy…is achieved by maintaining the SUA below the saturation point for urate (≤360 μmol/l) [4] 2.1 Adult patients currently prescribed (prescription in the last 2 months) allopurinol have a SUA measured in the last year ≥90%
2.2 Adult patients currently prescribed (prescription in the last 2 months) allopurinol have an SUA ≤ 360 μmol/l ≥80%
Monitoring of gout patients Annual measurements of plasma renal function and SUA [3] 3.1 Adult patients with a diagnosis of gout have had a SUA in the last year ≥90%
3.2 Adult patients with a diagnosis of gout have had a eGFR measured in the last year ≥90%
Lifestyle advice All patients with gout should be given advice about diet, alcohol restriction, weight management and fluid intake.[3, 4] 4.1 Adult patients with a diagnosis of gout with evidence of advice regarding diet recorded ≥90%
[It is recognised that such information may be provided in written format in a patient information leaflet] 4.2 Adult patients with a diagnosis of gout with evidence of advice regarding alcohol recorded ≥90%
4.3 Adult patients with a diagnosis of gout with evidence of advice regarding fluid intake recorded ≥90%
4.4 Adult patients with a diagnosis of gout have a record of BMI ≥90%
Addressing comorbidities Associated comorbidities and cardiovascular risk factors should be addressed as an important part of the management of gout [4] 5.1 Adult patients with a diagnosis of gout have a recorded CVD risk assessment score ≥90%
5.2 Adult patients with a diagnosis of gout and a 10 yr risk of CVD ≥20% are prescribed lipid lowering therapy ≥75%
Diuretic therapy should be stopped if possible in patients with a diagnosis of gout [3, 4] 5.3 Adult patients with a diagnosis of gout currently taking diuretics <25%
  1. CVD, Cardiovascular disease; eGFR, Estimated glomerular filtration rate; SUA, Serum uric acid.